Tom Willis
InvestorVenture Partner at Illumina Ventures · Board director at Rebus Biosystems
About
Tom Willis is a genomics entrepreneur who founded and exited two startups: ParAllele BioScience (acquired by Affymetrix in 2005) and Sequenta (merged with Adaptive Biotechnologies in 2015). He earlier led technology development at the Stanford Genome Technology Center and became CEO of Arima Genomics in June 2025.
Contact· self-published, not guessed
Board director at Rebus Biosystems
Intro paths
→
In turn, Tom can intro founders to Rebus Biosystems's investors below.
Rebus Biosystems's investors · 1
Co-founders at Rebus Biosystems
JR
Jekwan RyuExecutive Officer, Director
Colleagues at Illumina Ventures
Abhijit 'Ron' Mazumder, Ph.D.
Partner at Illumina Ventures
Abhijit "Ron" Mazumder
Partner at Illumina Ventures
Alexis Yongmei Ji
Partner at Illumina Ventures
Bill Rastetter
Advisor at Illumina Ventures
Bill Rastetter, Ph.D.
Advisor at Illumina Ventures
Charles Lin
Principal at Illumina Ventures
Charles White
Senior Associate at Illumina Ventures
Charles White, Ph.D.
Principal at Illumina Ventures
Frequently asked questions
- Who is Tom Willis?
- Tom Willis is a genomics entrepreneur who founded and exited two startups: ParAllele BioScience (acquired by Affymetrix in 2005) and Sequenta (merged with Adaptive Biotechnologies in 2015). He earlier led technology development at the Stanford Genome Technology Center and became CEO of Arima Genomics in June 2025.
- Where does Tom Willis work?
- Tom Willis is Venture Partner at Illumina Ventures and Board director at Rebus Biosystems.